ATOS
Atossa Genetics Inc
NASDAQ: ATOS · HEALTHCARE · BIOTECHNOLOGY
$5.37
+1.70% today
Updated 2026-04-30
Market cap
$49.09M
P/E ratio
—
P/S ratio
1,872.06x
EPS (TTM)
$-4.04
Dividend yield
—
52W range
$4 – $19
Volume
0.1M
Atossa Genetics Inc (ATOS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-62.70%
ROA
-37.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2009 | — | $-122857.00 | — | — | — |
| 2010 | — | $-1.09M | — | — | — |
| 2011 | $1500.00 | $-3.44M | -6,379.33% | -228,612.67% | -229,484.60% |
| 2012 | $481842.00 | $-5.08M | 86.38% | -1,052.01% | -1,054.26% |
| 2013 | $632558.00 | $-10.78M | 21.67% | -1,704.93% | -1,704.94% |
| 2014 | $40138.00 | $-14.66M | 100.00% | -30,322.96% | -36,518.83% |
| 2015 | $1758.00 | $-15.76M | -7,431.91% | -725,746.19% | -896,491.64% |
| 2016 | $0.00 | $-6.37M | — | — | — |
| 2017 | $0.00 | $-8.12M | — | — | — |
| 2018 | $0.00 | $-11.40M | — | — | — |
| 2019 | $0.00 | $-17.24M | — | — | — |
| 2020 | $0.00 | $-17.83M | — | — | — |
| 2021 | $0.00 | $-20.61M | — | — | — |
| 2022 | $0.00 | $-26.23M | — | — | — |
| 2023 | $0.00 | $-30.09M | — | — | — |
| 2024 | $0.00 | $-25.50M | — | — | — |
| 2025 | $0.00 | $-34.77M | — | — | — |